Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phleum pratense and Dactylis glomerata allergen extracts histamine equivalent prick test units
2024-514215-98-00Phase 2Completed
- Sponsor
- Inmunotek
- Start
- Nov 2024
- Modality
- Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allergovac depot and dactylis glomerata allergen extract in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), asthma and 2 more, sponsored by Inmunotek. Started Nov 2024; status: completed.
02
Drugs
allergovac depotdactylis glomerata allergen extract
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)asthmaTimothy grass pollen allergyOrchard grass pollen allergy
Beyond the preview
Go deeper on 2024-514215-98-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514215-98-00.